JW (Cayman) Therapeutics Co Ltd
HKEX:2126

Watchlist Manager
JW (Cayman) Therapeutics Co Ltd Logo
JW (Cayman) Therapeutics Co Ltd
HKEX:2126
Watchlist
Price: 3.05 HKD 1.33% Market Closed
Market Cap: 1.3B HKD

Wall Street
Price Targets

Price Targets Summary
JW (Cayman) Therapeutics Co Ltd

Wall Street analysts forecast JW (Cayman) Therapeutics Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for JW (Cayman) Therapeutics Co Ltd is 6.16 HKD with a low forecast of 6.1 HKD and a high forecast of 6.34 HKD.

Lowest
Price Target
6.1 HKD
100% Upside
Average
Price Target
6.16 HKD
102% Upside
Highest
Price Target
6.34 HKD
108% Upside
JW (Cayman) Therapeutics Co Ltd Competitors:
Price Targets
GLTO
Galecto Inc
2% Upside
688192
Dizal Jiangsu Pharmaceutical Co Ltd
56% Upside
603087
Gan & Lee Pharmaceuticals
2% Downside
7774
Japan Tissue Engineering Co Ltd
154% Upside
1530
3SBio Inc
38% Upside
MNKD
MannKind Corp
56% Upside
688235
Beigene Ltd
34% Upside
ALXO
ALX Oncology Holdings Inc
108% Upside

Revenue
Forecast

Revenue Estimate
JW (Cayman) Therapeutics Co Ltd

The compound annual growth rate of JW (Cayman) Therapeutics Co Ltd's revenue for the next 4 years is 74%.

N/A
Past Growth
74%
Estimated Growth
Estimates Accuracy
-17%
Average Miss

Operating Income
Forecast

Operating Income Estimate
JW (Cayman) Therapeutics Co Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Net Income
Forecast

Net Income Estimate
JW (Cayman) Therapeutics Co Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
4%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is JW (Cayman) Therapeutics Co Ltd's stock price target?
Price Target
6.16 HKD

According to Wall Street analysts, the average 1-year price target for JW (Cayman) Therapeutics Co Ltd is 6.16 HKD with a low forecast of 6.1 HKD and a high forecast of 6.34 HKD.

What is JW (Cayman) Therapeutics Co Ltd's Revenue forecast?
Projected CAGR
74%

The compound annual growth rate of JW (Cayman) Therapeutics Co Ltd's revenue for the next 4 years is 74%.

Back to Top